ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,847Medicare Part D Prescriptions Filled, Including Refills

Rank: 381 out of 2399

$703K Total Retail Price of All Prescriptions

Rank: 423 out of 2399

612 Patients Receiving at Least One Drug in Part D
92% Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Pennsylvania
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 612 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 612 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
METOPROLOL TARTRATE 518 513* 115 1 8
FUROSEMIDE 487 487 96 2 6
SIMVASTATIN 388 371 92 3 1
ATORVASTATIN CALCIUM 342 337* 91 4 7
LEVOTHYROXINE SODIUM 328 323* 69 5 2
CLOPIDOGREL 290 285* 57 6 14
FELODIPINE ER 277 272* 56 7 136
WARFARIN SODIUM 272 267* 48 8 10
AMLODIPINE BESYLATE 251 246* 52 9 4
LISINOPRIL 241 227 66 10 3
HYDROCHLOROTHIAZIDE 239 234* 66 11 11
LORAZEPAM 239 234* 63 B 11 19
TRAMADOL HCL 218 204 76 13 25
OMEPRAZOLE 211 192 51 14 5
DONEPEZIL HCL 192 192 37 15 26
PANTOPRAZOLE SODIUM 185 180* 35 16 20
HYDROCODONE-ACETAMINOPHEN 163 158* 33 S3 17 15
TAMSULOSIN HCL 163 158* 37 17 27
POTASSIUM CHLORIDE 160 155* 34 19 21
LOSARTAN POTASSIUM 152 147* 40 20 16
PAROXETINE HCL 147 125 34 21 73
TRIAMTERENE-HCTZ 143 138* 34 22 58
ISOSORBIDE MONONITRATE ER 141 136* 26 23 36
ESCITALOPRAM OXALATE 135 135 26 24 39
ALPRAZOLAM 134 116 25 B 25 23
GLIPIZIDE 132 119 34 26 53
METFORMIN HCL 131 114 35 27 9
AZITHROMYCIN 130 125* 97 28 47
PREDNISONE 130 130 36 28 38
ALENDRONATE SODIUM 127 116 30 30 34
DIOVAN 125 120* 30 31 30
METOPROLOL SUCCINATE 122 117* 31 32 12
DIGOX 108 108 21 33 62
MELOXICAM 108 103* 32 33 68
NEXIUM 104 99* 19 35 35
GLYBURIDE 101 96* 38 R 36 96
ENALAPRIL MALEATE 95 95 22 37 67
IBUPROFEN 93 88* 37 38 81
CIPROFLOXACIN HCL 92 87* 71 39 80
ATENOLOL 91 72 17 40 13
RANITIDINE HCL 89 72 22 41 45
ALLOPURINOL 81 76* 23 42 32
SYNTHROID 81 76* 23 42 40
FAMOTIDINE* 80 80 13 44 60
MIRTAZAPINE 79 74* 17 45 41
PROPRANOLOL HCL 77 77 13 46 129
GABAPENTIN 76 71* 21 47 17
LANTUS SOLOSTAR 76 71* 16 47 82
NOVOLIN R 75 70* 12 49 254
DILTIAZEM 24HR ER 74 69* 17 50 75
SPIRONOLACTONE 73 68* 15 51 71
VOLTAREN 72 72 27 52 138
MONTELUKAST SODIUM 72 67* 16 52 56
CITALOPRAM HBR 70 65* 20 54 22
NOVOLIN N 63 58* 12 55 295
ZOLPIDEM TARTRATE 62 49 18 56 29
LABETALOL HCL 58 <11 <11 57 155
LEVETIRACETAM 57 <11 <11 58 93
FENTANYL 52 <11 <11 S2 59 76
INSULIN SYRINGE* 52 47* 15 59 237
VENTOLIN HFA 51 46* 21 61 101
PRAVASTATIN SODIUM 50 45* 14 62 18
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.